PHARMAIDS PH Fact Sheet, PHARMAIDS PH Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PHARMAIDS PH Fact Sheet    (PHPH)


Revealing on July 30th: Asset Class Outlook and Economic View Post Covid 19


Here is the latest financial fact sheet of PHARMAIDS PH. For more details, see the PHARMAIDS PH quarterly results and PHARMAIDS PH share price and chart. For a sector overview, read our pharmaceuticals sector report.

PHARMAIDS PH Price History

Price Rs 15.9
Mkt Cap Rs m 164
Vol '000 1.9
P/E X 160.7
P/CF X 226.7
EPS (TTM) Rs 0.1
% ch % -4.8
No. of shares m 10.31
% ch week % -0.6
% ch 1-mth % -14.1
% ch 12-mth % 238.3
52 week H/L Rs 30.4/2.7
(As on Jul 27, 2021 03:35:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

PHARMAIDS PH Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
PHARMAIDS PH EQUITY SHARE DATA
High Rs65455 
Low Rs32325 
Sales per share (Unadj.) Rs4.93.51.30.50 
Earnings per share (Unadj.) Rs-1.20.3-1.1-0.20 
Diluted earnings per shareRs-0.40.1-0.4-0.20.0 
Cash flow per share (Unadj.) Rs-0.90.5-1.1-0.10.1 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Dividend yield (eoy) %00000 
Book value per share (Unadj.) Rs3.94.23.18.18.2 
Adj. book value per shareRs1.31.41.08.18.2 
Shares outstanding (eoy) m3.413.413.4110.3110.31 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x0.91.12.46.3NM 
Avg P/E ratio x-3.811.6-2.8-20.0146.2 
P/CF ratio (eoy) x-5.17.3-2.8-26.967.8 
Price / Book Value ratio x1.10.91.10.40.6 
Dividend payout %00000 
Avg Mkt Cap Rs m1513113549 
No. of employees `000NANANANANA 
Total wages/salary Rs m22100 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
PHARMAIDS PH INCOME DATA
Net Sales Rs m1712460 
Other income Rs m00000 
Total revenues Rs m1712560 
Gross profit Rs m-32-4-1-3 
Depreciation Rs m11000 
Interest Rs m00000 
Profit before tax Rs m-41-4-1-4 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m0000-4 
Profit after tax Rs m-41-4-20 
Gross profit margin %-20.514.7-86.0-18.1NM 
Effective tax rate %8.0-33.2-4.7-24.0109.0 
Net profit margin %-23.69.1-85.9-31.6NM 
PHARMAIDS PH BALANCE SHEET DATA
Current assets Rs m151684411 
Current liabilities Rs m75220 
Net working cap to sales %51.094.8116.7743.7NM 
Current ratio x2.33.33.321.345.8 
Inventory Days Days701154402,447NM 
Debtors Days Days233239419579NM 
Net fixed assets Rs m8454370 
Share capital Rs m343434103103 
"Free" reserves Rs m-20-19-23-19-18 
Net worth Rs m1314108484 
Long term debt Rs m30000 
Total assets Rs m2320138781 
Interest coverage x-13.93.1-367.0-142.0-374.0 
Debt to equity ratio x0.20000 
Sales to assets ratio x0.70.60.30.10 
Return on assets %-16.17.4-29.7-2.00.4 
Return on equity %-30.27.7-37.0-2.10.4 
Return on capital %-25.48.6-35.2-1.7-4.4 
Exports to sales %0000NM 
Imports to sales %0000NM 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m00000 
Fx outflow Rs m00000 
Net fx Rs m00000 
PHARMAIDS PH CASH FLOW
From Operations Rs m 0 3 -2 -1 -7 
From Investments Rs m -1 3 -1 0 7 
From Financial Activity Rs m 0 -2 -1 0 0 
Net Cashflow Rs m 0 4 -4 -1 -1 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Indian Promoters 65.8%
Foreign collaborators 0.0%
Indian inst/Mut Fund 0.0%
FIIs 0.0%
ADR/GDR 0.0%
Free float 34.2%
Shareholders 7,192
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 4-4-211/212/3, 1st Floor sultan Bazar, Inderbagh, Hyderabad - 500095
E-MAIL miailpharniaids@yahoo.co.in WEB www.pharmaids.com
TEL 040-40122151 FAX
SECTOR TRADING GROUP Private sector
TR AGENT Venture Capital & Corporate Investments Ltd, 12-10-167, MIG- 167, Bharat Nagar Colony
YEAR OF INC: 1989 BSE CODE: 524572 FV (Rs): 10 DIV YIELD (%): -

More Trading Company Fact Sheets:   JENBURKT PH.  GUFIC BIOSCIENCE  BH.IMMUN&BIO  LYKA LABS  GRANULES INDIA  

Compare PHARMAIDS PH With:   JENBURKT PH.  GUFIC BIOSCIENCE  BH.IMMUN&BIO  LYKA LABS  GRANULES INDIA  




Today's Market

Sensex Ends 274 Points Lower; Dr Reddy's Laboratories and Cipla Among Top Nifty Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Views on news

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying (Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

KIMS Shares Make Strong Debut Listing at a 22% Premium (Views On News)

Jun 28, 2021

KIMS shares pare gains after making a strong debut on the exchanges.

More Views on News

Most Popular

RBI Opens a New Market for Investors (Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

These Are the Best Stocks to Own (Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

A Better Way than the Zomato IPO to Play the Food Delivery Megatrend (Profit Hunter)

Jul 14, 2021

A unique backdoor way of making big profits from smallcap companies.

Heads Up Bank Nifty Traders (Fast Profits Daily)

Jul 14, 2021

The RBI raised bond yields on 10yr benchmark paper. That can impact Bank Nifty traders in the coming days.

India's Vulture Moment Against China (Fast Profits Daily)

Jul 15, 2021

India has a great opportunity to grab market share from China. Profit from it.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK PHARMAIDS PH

  • Track your investment in PHARMAIDS PH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PHARMAIDS PH

PHARMAIDS PH - COMPUAGE INFOCOM COMPARISON

COMPARE PHARMAIDS PH WITH

MARKET STATS